Truven Health Analytics® published data in the HealthLeaders Media September 2017 Fact File from our study on high-cost claimants (HCC) produced by analyzing our MarketScan® commercial claims database. The top 1% of claimants were selected and categorized into 10 distinct subpopulations. Patients undergoing active cancer treatment made up 23.51% of the HCC, the second-largest group.
Published: April 2018
Copyright © 2018 HealthLeaders Media, an H3.Group Brand. All rights reserved.
100 Winners Circle, Suite 300 | Brentwood, TN 37027